| Literature DB >> 26623965 |
Abstract
Scarring is a lifelong, physically disfiguring and often emotionally debilitating sequela resulting from acne vulgaris. Nearly 80% of patients have some scarring and 50% have clinically relevant scarring. Although the extent, duration, and intensity of inflammation are important risk factors, scarring also can develop in patients with relatively mild inflammation. Assessment of scarring should be part of the evaluation in all patients with acne and should be a consideration in determining treatment. Semin Cutan Med Surg 34(supp5):S89-S91Entities:
Keywords: Acne vulgaris; isotretinoin; scarring
Year: 2015 PMID: 26623965 DOI: 10.12788/j.sder.2015.0164
Source DB: PubMed Journal: Semin Cutan Med Surg ISSN: 1085-5629